IMMUNOHISTOCHEMICAL EXPRESSION OF KI-67 AND P53 IN BREAST CARCINOMA

Authors

  • Snober, Sumaira Ahmed

DOI:

https://doi.org/10.25215/0557983827.10

Abstract

Breast carcinoma remains the most common malignancy among women worldwide and represents a major cause of cancer-related mortality. Advances in molecular pathology have improved the understanding of tumour biology and facilitated the identification of prognostic and predictive biomarkers. Among these, Ki-67 and p53 are widely studied immunohistochemical markers that provide valuable information regarding tumor proliferation and genetic alterations. Ki-67 serves as an indicator of cellular proliferative activity, while p53 reflects abnormalities in the tumour suppressor pathway. The expression patterns of these biomarkers have been associated with tumour grade, stage, molecular subtype [e.g. HER2 enriched and Luminal B], therapeutic response, and patient survival. This chapter discusses the biological basis, immunohistochemical assessment, clinicopathological significance, and prognostic implications of Ki-67 and p53 expression in breast carcinoma.

Published

2026-07-03